Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Convento, M., Pessoa, E., Arago, A., Schor, N
Once FDA-approved (expected 2027), the commercial price will likely be $1,0001,500/month before insurance, based on tirzepatide and semaglutide pricing
The trials covered different patient populations and dose ranges and compared them with other diabetes drugs
Substituting the primary amide with a cyano group and methyl group significantly improved potency
US$ 24.24
US$ 25.76
US$ 28.17
US$ 21.83
US$ 21.01
US$ 27.05
US$ 27.69
US$ 20.97
US$ 23.54
US$ 19.99
